These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 25385751)

  • 21. "It's a maybe test": men's experiences of prostate specific antigen testing in primary care.
    Evans R; Edwards AG; Elwyn G; Watson E; Grol R; Brett J; Austoker J
    Br J Gen Pract; 2007 Apr; 57(537):303-10. PubMed ID: 17394734
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Limited Evidence of Shared Decision Making for Prostate Cancer Screening in Audio-Recorded Primary Care Visits Among Black Men and their Healthcare Providers.
    Stevens ER; Thomas J; Martinez-Lopez N; Fagerlin A; Ciprut S; Shedlin M; Gold HT; Li H; Davis JK; Campagna A; Bhat S; Warren R; Ubel P; Ravenell JE; Makarov DV
    J Immigr Minor Health; 2024 Oct; 26(5):866-877. PubMed ID: 38822923
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prostate specific antigen testing in family practice: a cross sectional survey of self-reported rates of and reasons for testing participation and risk disclosure.
    Carey M; Bryant J; Yoong SL; Russell G; Barker D; Sanson-Fisher R
    BMC Fam Pract; 2013 Dec; 14():186. PubMed ID: 24321004
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Role of Prostate-specific Antigen Persistence After Radical Prostatectomy for the Prediction of Clinical Progression and Cancer-specific Mortality in Node-positive Prostate Cancer Patients.
    Bianchi L; Nini A; Bianchi M; Gandaglia G; Fossati N; Suardi N; Moschini M; Dell'Oglio P; Schiavina R; Montorsi F; Briganti A
    Eur Urol; 2016 Jun; 69(6):1142-8. PubMed ID: 26749093
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prostate-Specimen Antigen (PSA) Screening and Shared Decision Making Among Deaf and Hearing Male Patients.
    Kushalnagar P; Hill C; Carrizales S; Sadler GR
    J Cancer Educ; 2020 Feb; 35(1):28-35. PubMed ID: 30353474
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rising PSA after a radical treatment.
    Carroll P
    Eur Urol; 2001; 40 Suppl 2():9-16. PubMed ID: 11684859
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictors of mortality after androgen-deprivation therapy in patients with rapidly rising prostate-specific antigen levels after local therapy for prostate cancer.
    Rodrigues NA; Chen MH; Catalona WJ; Roehl KA; Richie JP; D'Amico AV
    Cancer; 2006 Aug; 107(3):514-20. PubMed ID: 16795068
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Informed decision making on PSA testing for the detection of prostate cancer: an evaluation of a leaflet with risk indicator.
    van Vugt HA; Roobol MJ; Venderbos LD; Joosten-van Zwanenburg E; Essink-Bot ML; Steyerberg EW; Bangma CH; Korfage IJ
    Eur J Cancer; 2010 Feb; 46(3):669-77. PubMed ID: 20022239
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regret and fear in prostate cancer: The relationship between treatment appraisals and fear of recurrence in prostate cancer survivors.
    Maguire R; Hanly P; Drummond FJ; Gavin A; Sharp L
    Psychooncology; 2017 Nov; 26(11):1825-1831. PubMed ID: 28124398
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association between features of patient-provider discussions and routine prostate-specific antigen testing.
    Liao JM; Ommerborn MJ; Clark CR
    PLoS One; 2017; 12(5):e0177687. PubMed ID: 28520820
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Confidence and uncertainty long after initial treatment for early prostate cancer: survivors' views of cancer control and the treatment decisions they made.
    Clark JA; Talcott JA
    J Clin Oncol; 2006 Sep; 24(27):4457-63. PubMed ID: 16983114
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Psychosocial trajectories of men monitoring prostate-specific antigen levels following surgery for prostate cancer.
    Bailey DE; Wallace Kazer M; Polascik TJ; Robertson C
    Oncol Nurs Forum; 2014 Jul; 41(4):361-8. PubMed ID: 24969246
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Does Choline PET/CT Change the Management of Prostate Cancer Patients With Biochemical Failure?
    Goldstein J; Even-Sapir E; Ben-Haim S; Saad A; Spieler B; Davidson T; Berger R; Weiss I; Appel S; Lawrence YR; Symon Z
    Am J Clin Oncol; 2017 Jun; 40(3):256-259. PubMed ID: 25319322
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Promoting prostate-specific antigen informed decision-making. Evaluating two community-level interventions.
    Driscoll DL; Rupert DJ; Golin CE; McCormack LA; Sheridan SL; Welch BM; Poehlman JA
    Am J Prev Med; 2008 Aug; 35(2):87-94. PubMed ID: 18617077
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Initiation of salvage therapy for prostate cancer.
    Johnstone PA; Booth R; Riffenburgh RH; Amling CL; Kane CJ; Moul JW
    Prostate Cancer Prostatic Dis; 2002; 5(2):136-43. PubMed ID: 12497004
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correlation of clinical and pathologic factors with rising prostate-specific antigen profiles after radical prostatectomy alone for clinically localized prostate cancer.
    Kupelian P; Katcher J; Levin H; Zippe C; Klein E
    Urology; 1996 Aug; 48(2):249-60. PubMed ID: 8753737
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PSA doubling time as a predictor of clinical progression after biochemical failure following radical prostatectomy for prostate cancer.
    Roberts SG; Blute ML; Bergstralh EJ; Slezak JM; Zincke H
    Mayo Clin Proc; 2001 Jun; 76(6):576-81. PubMed ID: 11393495
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Men considering a hypothetical treatment for prostate cancer: a comparison to patients.
    Van Manen L; Feldman-Stewart D; Brundage MD
    Patient Educ Couns; 2006 Apr; 61(1):33-42. PubMed ID: 16257170
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical impact of
    Albisinni S; Artigas C; Aoun F; Biaou I; Grosman J; Gil T; Hawaux E; Limani K; Otte FX; Peltier A; Sideris S; Sirtaine N; Flamen P; van Velthoven R
    BJU Int; 2017 Aug; 120(2):197-203. PubMed ID: 27981732
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Informed Decision Making: Assessment of the Quality of Physician Communication about Prostate Cancer Diagnosis and Treatment.
    Holmes-Rovner M; Montgomery JS; Rovner DR; Scherer LD; Whitfield J; Kahn VC; Merkle EC; Ubel PA; Fagerlin A
    Med Decis Making; 2015 Nov; 35(8):999-1009. PubMed ID: 26304063
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.